Comprehensive Analysis of 5-Aminolevulinic Acid Dehydrogenase (ALAD) Variants and Renal Cell Carcinoma Risk among Individuals Exposed to Lead. Here, ALAD is linked to hereditary clear cell renal cell carcinoma.